Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by valueman1 on Nov 01, 2021 12:25pm

News

Cannot recall the last time we had news relating to treatment. Sooo dissatisfied with this company. How much time and excuses do they need.
signed
frustrated shareholder
Comment by gojotv! on Nov 01, 2021 1:40pm
I laughed out loud at this post. Theralase is in a Phase2 testing period for its revolutionary cancer-killing drug and protocol. We don't do "news" The bashers are herding, just in time for the upcoming results announcement. They know it's gonna be good. And if you really are an investor, (bwaa-haa!) and you really are this stupid... take Warren Buffet's advice... Only invest ...more  
Comment by stocksnbonds458 on Nov 01, 2021 6:14pm
I am frustrated as well, have called IR a few times and twice left messages--no reply. I also called customer service today, that went straight to voicemail. Their Twitter site hasn't been updated in 5 months, wtf? Very unprofessional imo. One of my questions would be the reason for pulling the recent job postings. Not looking to have my hand held and comforted, but it would be nice to chat ...more  
Comment by floatinketucky on Nov 01, 2021 7:11pm
Shawn has recently left the company. Things are going on here. Just a heads down period for now.  Have a nice day.  Cheers. TLTFF long.
Comment by anabelsi on Nov 01, 2021 7:24pm
Same here, no response. I have been invested in this company for more than 5 years and I obviously want the phase 2 study to succeed. Pointing out that TLT handles investor relations very poorly is not bashing, it’s a fact. How much time or effort would it take them to at the very least update Twitter? Like ok fine, you don't want to respond to calls or even emails, but you can't even ...more  
Comment by gojotv! on Nov 01, 2021 11:50pm
Hooboy, the new herd of bashers (who I've never seen on this board before) are doubling down on the "stupid", lol. This is a Phase2 testing period. Results have to be compiled and analyzed, and will be announced all together when they are revealed to be statistically relevant. That's the way it goes. If you're trying to capitalize on the nerves and ignorance of new investors ...more  
Comment by Zzzzzzzzzzz on Nov 02, 2021 5:14pm
If this is as big as you might think, would it not be prudent for Rodger to maintain his and everyone in the office their silence? I believe Rodger will not be rubbing the exc the wrong way for anyone. I keep hearing that they have no secretary, she’s likely there, just not for public to ask questions she cannot  or will not answer, at least not now. 
Comment by skys1 on Nov 02, 2021 5:21pm
Zzzzzz - That's nonsense. I communicated with her last week. I don't know how all you people come up with all this stuff. 
Comment by stocksnbonds458 on Nov 02, 2021 7:14pm
Her??? Skys I have been put through to the Invertor relations voicemail a number of times, it is a man's voice. (who by the way has never got back to me in the 3 weeks I have been calling) Who specifically are you referring to? The other option when calling the main number is Customer Service, that one simplsy wasn't answered when i tried. Many here are making excuses for their lack of ...more  
Comment by tamarindo1 on Nov 02, 2021 7:31pm
Call Kristina.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250